3 For life: A model pilot program to prevent hepatitis B virus infection and liver cancer in Asian and Pacific Islander Americans

American Journal of Health Promotion

Volumn 23, Issue 3, 2009, Pages 176-181

  Chang, Ellen T ^a,b,c   Sue, Eric ^c   Zola, Janet ^d   So, Samuel K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHERN CALIFORNIA CANCER CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

^d SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Asian Americans; Community health centers; Geographic location: San Francisco; Health focus: physical health; Hepatitis B; Liver cancer; Manuscript format: research; Outcome measure: behavioral; Pacific Islander Americans; Prevention research; Race ethnicity: Asian and Pacific Islander Americans; Research purpose: program evaluation; Setting: local community; Strategy: education and behavior change; Study design: nonexperimental; Target population age: adults; Target population circumstances: education income: all education and income levels

Indexed keywords

EID: 58449086035     PISSN: 08901171     EISSN: None     Source Type: Journal    
DOI: 10.4278/ajhp.071025115     Document Type: Article

References (13)

1. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158-S168.
2. World Health Organization: Hepatitis B Fact Sheet No204. Revised October 2000. Available al: http://www.who.int/mediacentre/factsheets/fs204/cn/. Accessed December 18, 2007.
3. Wu CA, Lin SY, So SK, Chang ET. Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev. 2007;8:127-134.
4. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46:1034-1040.
5. Mast EE, Weinbaum CM, Fiorc AE, et al, for the Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006;55:1-33.
6. UCLA Center for Health Policy Research: California Health Interview Survey (CHIS) 2005. Available at: http://www.chis.ucla.edu. Accessed December 18, 2007.
7. Thoelen S, Van Damme P, Leentvaar-Kuypers A, et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine. 1999;17:1657-1662.
8. Louther J, Feldman J, Rivera P, et al. Hepatitis B vaccination program at a New York City hospital: seroprevalence, seroconversion, and declination. Am J Infect Control. 1998;26:423-427.
9. Doebbeling BN, Ferguson KJ, Kohout FJ. Predictors of hepatitis B vaccine acceptance in health care workers. Med. Care. 1996;34:58-72.
10. Altice FL, Bruce RD, Walton MR, Buitrago MI. Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health. 2005;82:151-161.
11. Campbell JV, Garfein RS, Thiede H, et al. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend. 2007;91(suppl 1):S64-S72.
12. Sansom S, Rudy E, Strine T, Douglas W. Hepatitis A and B vaccination in a sexually transmitted disease clinic for men who have sex with men. Sex Transm Dis. 2003;30:685-688.
13. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132:1005-1022.